APA (7th ed.) Citation

N, S., T, Y., N, K., R, O., S, Y., T, M., . . . F, I. (2022). Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice. International journal of hematology, 115(2), 198. https://doi.org/10.1007/s12185-021-03239-y

Chicago Style (17th ed.) Citation

N, Saito, et al. "Circulating CD34+ cells of Primary Myelofibrosis Patients Contribute to Myeloid-dominant Hematopoiesis and Bone Marrow Fibrosis in Immunodeficient Mice." International Journal of Hematology 115, no. 2 (2022): 198. https://doi.org/10.1007/s12185-021-03239-y.

MLA (9th ed.) Citation

N, Saito, et al. "Circulating CD34+ cells of Primary Myelofibrosis Patients Contribute to Myeloid-dominant Hematopoiesis and Bone Marrow Fibrosis in Immunodeficient Mice." International Journal of Hematology, vol. 115, no. 2, 2022, p. 198, https://doi.org/10.1007/s12185-021-03239-y.